1
|
Wang YL, Ni Q, Zeng WH, Feng H, Cai WF, Chen QC, Lin SX, Jiang CP, Yi YK, Shen Q, Shen CY. Antioxidant, Antimicrobial, and Anti-Inflammatory Effects of Liriodendron chinense Leaves. ACS OMEGA 2024; 9:27002-27016. [PMID: 38947843 PMCID: PMC11209703 DOI: 10.1021/acsomega.3c10269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/22/2023] [Revised: 05/14/2024] [Accepted: 05/22/2024] [Indexed: 07/02/2024]
Abstract
Liriodendron chinense has been widely utilized in traditional Chinese medicine to treat dispelling wind and dampness and used for alleviating cough and diminishing inflammation. However, the antioxidant, antimicrobial, and anti-inflammatory effects of L. chinense leaves and the key active constituents remained elusive. So, we conducted some experiments to support the application of L. chinense in traditional Chinese medicine by investigating the antioxidant, antibacterial, and anti-inflammatory abilities, and to identify the potential key constituents responsible for the activities. The ethanol extract of L. chinense leaves (LCLE) was isolated and extracted, and assays measuring ferric reducing antioxidant power, total reducing power, DPPH•, ABTS•+, and •OH were used to assess its in vitro antioxidant capacities. Antimicrobial activities of LCLE were investigated by minimal inhibitory levels, minimum antibacterial concentrations, disc diffusion test, and scanning electron microscope examination. Further, in vivo experiments including macro indicators examination, histopathological examination, and biochemical parameters measurement were conducted to investigate the effects of LCLE on lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice. LCLE was further isolated and purified through column chromatography, and LPS-induced RAW264.7 cells were constructed to assess the diminished inflammation potential of the identified chemical composites. ABTS•+ and •OH radicals were extensively neutralized by the LCLE treatment. LCLE administration also presented broad-spectrum antimicrobial properties, especially against Staphylococcus epidermidis by disrupting cell walls. LPS-induced ALI in mice was significantly ameliorated by LCLE intervention, as evidenced by the histological changes in the lung and liver tissues as well as the reductions of nitric oxide (NO), TNF-α, and IL-6 production. Furthermore, three novel compounds including fragransin B2, liriodendritol, and rhamnocitrin were isolated, purified, and identified from LCLE. These three compounds exhibited differential regulation on NO accumulation and IL-10, IL-1β, IL-6, TNF-α, COX-2, and iNOS mRNA expression in RAW264.7 cells induced by LPS. Fragransin B2 was more effective in inhibiting TNF-α mRNA expression, while rhamnocitrin was more powerful in inhibiting IL-6 mRNA expression. LCLE had significant antioxidant, antimicrobial, and anti-inflammatory effects. Fragransin B2, liriodendritol, and rhamnocitrin were probably key active constituents of LCLE, which might act synergistically to treat inflammatory-related disorders. This study provided a valuable view of the healing potential of L. chinense leaves in curing inflammatory diseases.
Collapse
Affiliation(s)
- Ya-Li Wang
- School
of Traditional Chinese Medicine, Southern
Medical University, Guangzhou 510515, China
- Guangdong
Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Southern Medical University, Guangzhou 510515, China
- Guangdong
Basic Research Center of Excellence for Integrated Traditional and
Western Medicine for Qingzhi Diseases, Guangzhou 510515, China
| | - Qian Ni
- School
of Traditional Chinese Medicine, Southern
Medical University, Guangzhou 510515, China
- Guangdong
Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Southern Medical University, Guangzhou 510515, China
- Guangdong
Basic Research Center of Excellence for Integrated Traditional and
Western Medicine for Qingzhi Diseases, Guangzhou 510515, China
| | - Wen-Hao Zeng
- School
of Traditional Chinese Medicine, Southern
Medical University, Guangzhou 510515, China
- Guangdong
Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Southern Medical University, Guangzhou 510515, China
- Guangdong
Basic Research Center of Excellence for Integrated Traditional and
Western Medicine for Qingzhi Diseases, Guangzhou 510515, China
| | - Hui Feng
- School
of Traditional Chinese Medicine, Southern
Medical University, Guangzhou 510515, China
- Guangdong
Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Southern Medical University, Guangzhou 510515, China
- Guangdong
Basic Research Center of Excellence for Integrated Traditional and
Western Medicine for Qingzhi Diseases, Guangzhou 510515, China
| | - Wei-Feng Cai
- School
of Traditional Chinese Medicine, Southern
Medical University, Guangzhou 510515, China
- Guangdong
Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Southern Medical University, Guangzhou 510515, China
- Guangdong
Basic Research Center of Excellence for Integrated Traditional and
Western Medicine for Qingzhi Diseases, Guangzhou 510515, China
| | - Qi-Cong Chen
- School
of Traditional Chinese Medicine, Southern
Medical University, Guangzhou 510515, China
- Guangdong
Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Southern Medical University, Guangzhou 510515, China
- Guangdong
Basic Research Center of Excellence for Integrated Traditional and
Western Medicine for Qingzhi Diseases, Guangzhou 510515, China
| | - Song-Xia Lin
- School
of Traditional Chinese Medicine, Southern
Medical University, Guangzhou 510515, China
- Guangdong
Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Southern Medical University, Guangzhou 510515, China
- Guangdong
Basic Research Center of Excellence for Integrated Traditional and
Western Medicine for Qingzhi Diseases, Guangzhou 510515, China
| | - Cui-Ping Jiang
- School
of Traditional Chinese Medicine, Southern
Medical University, Guangzhou 510515, China
- Guangdong
Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Southern Medical University, Guangzhou 510515, China
- Guangdong
Basic Research Center of Excellence for Integrated Traditional and
Western Medicine for Qingzhi Diseases, Guangzhou 510515, China
| | - Yan-Kui Yi
- School
of Traditional Chinese Medicine, Southern
Medical University, Guangzhou 510515, China
- Guangdong
Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Southern Medical University, Guangzhou 510515, China
- Guangdong
Basic Research Center of Excellence for Integrated Traditional and
Western Medicine for Qingzhi Diseases, Guangzhou 510515, China
| | - Qun Shen
- School
of Traditional Chinese Medicine, Southern
Medical University, Guangzhou 510515, China
- Guangdong
Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Southern Medical University, Guangzhou 510515, China
- Guangdong
Basic Research Center of Excellence for Integrated Traditional and
Western Medicine for Qingzhi Diseases, Guangzhou 510515, China
| | - Chun-Yan Shen
- School
of Traditional Chinese Medicine, Southern
Medical University, Guangzhou 510515, China
- Guangdong
Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Southern Medical University, Guangzhou 510515, China
- Guangdong
Basic Research Center of Excellence for Integrated Traditional and
Western Medicine for Qingzhi Diseases, Guangzhou 510515, China
| |
Collapse
|
2
|
Oyama Y, Shuff SR, Burns N, Vohwinkel CU, Eckle T. Intense light-elicited alveolar type 2-specific circadian PER2 protects from bacterial lung injury via BPIFB1. Am J Physiol Lung Cell Mol Physiol 2022; 322:L647-L661. [PMID: 35272486 PMCID: PMC9037706 DOI: 10.1152/ajplung.00301.2021] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
Abstract
Circadian amplitude enhancement has the potential to be organ protective but has not been studied in acute lung injury (ALI). Consistent light and dark cycles are crucial for the amplitude regulation of the circadian rhythm protein Period2 (PER2). Housing mice under intense instead of ambient light for 1 wk (light: dark cycle:14h:10h), we demonstrated a robust increase of pulmonary PER2 trough and peak levels, which is consistent with circadian amplitude enhancement. A search for the affected lung cell type suggested alveolar type 2 (ATII) cells as strong candidates for light induction of PER2. A head-to-head comparison of mice with cell-type-specific deletion of Per2 in ATII, endothelial, or myeloid cells uncovered a dramatic phenotype in mice with an ATII-specific deletion of Per2. During Pseudomonas aeruginosa-induced ALI, mice with Per2 deletion in ATII cells showed 0% survival, whereas 85% of control mice survived. Subsequent studies demonstrated that intense light therapy dampened lung inflammation or improved the alveolar barrier function during P. aeruginosa-induced ALI, which was abolished in mice with an ATII-specific deletion of Per2. A genome-wide mRNA array uncovered bactericidal/permeability-increasing fold-containing family B member 1 (BPIFB1) as a downstream target of intense light-elicited ATII-PER2 mediated lung protection. Using the flavonoid and PER2 amplitude enhancer nobiletin, we recapitulated the lung-protective and anti-inflammatory effects of light and BPIFB1, respectively. Together, our studies demonstrate that light-elicited amplitude enhancement of ATII-specific PER2 is a critical control point of inflammatory pathways during bacterial ALI.
Collapse
Affiliation(s)
- Yoshimasa Oyama
- 1Department of Anesthesiology, University of Colorado Denver School of Medicine, Aurora, Colorado,2Department of Anesthesiology and Intensive Care Medicine, Oita University Faculty of Medicine, Oita, Japan
| | - Sydney R. Shuff
- 1Department of Anesthesiology, University of Colorado Denver School of Medicine, Aurora, Colorado
| | - Nana Burns
- 3Developmental Lung Biology, Cardiovascular Pulmonary Research Laboratories, Division of Pediatric Critical Care, Department of Medicine and Pediatrics, University of Colorado, Aurora, Colorado
| | - Christine U. Vohwinkel
- 3Developmental Lung Biology, Cardiovascular Pulmonary Research Laboratories, Division of Pediatric Critical Care, Department of Medicine and Pediatrics, University of Colorado, Aurora, Colorado
| | - Tobias Eckle
- 1Department of Anesthesiology, University of Colorado Denver School of Medicine, Aurora, Colorado,4Department of Cell and Developmental Biology, University of Colorado Denver School of Medicine, Aurora, Colorado
| |
Collapse
|
3
|
Bachmaier K, Stuart A, Singh A, Mukhopadhyay A, Chakraborty S, Hong Z, Wang L, Tsukasaki Y, Maienschein-Cline M, Ganesh BB, Kanteti P, Rehman J, Malik AB. Albumin Nanoparticle Endocytosing Subset of Neutrophils for Precision Therapeutic Targeting of Inflammatory Tissue Injury. ACS NANO 2022; 16:4084-4101. [PMID: 35230826 PMCID: PMC8945372 DOI: 10.1021/acsnano.1c09762] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/03/2021] [Accepted: 02/23/2022] [Indexed: 05/30/2023]
Abstract
The complex involvement of neutrophils in inflammatory diseases makes them intriguing but challenging targets for therapeutic intervention. Here, we tested the hypothesis that varying endocytosis capacities would delineate functionally distinct neutrophil subpopulations that could be specifically targeted for therapeutic purposes. By using uniformly sized (∼120 nm in diameter) albumin nanoparticles (ANP) to characterize mouse neutrophils in vivo, we found two subsets of neutrophils, one that readily endocytosed ANP (ANPhigh neutrophils) and another that failed to endocytose ANP (ANPlow population). These ANPhigh and ANPlow subsets existed side by side simultaneously in bone marrow, peripheral blood, spleen, and lungs, both under basal conditions and after inflammatory challenge. Human peripheral blood neutrophils showed a similar duality. ANPhigh and ANPlow neutrophils had distinct cell surface marker expression and transcriptomic profiles, both in naive mice and in mice after endotoxemic challenge. ANPhigh and ANPlow neutrophils were functionally distinct in their capacities to kill bacteria and to produce inflammatory mediators. ANPhigh neutrophils produced inordinate amounts of reactive oxygen species and inflammatory chemokines and cytokines. Targeting this subset with ANP loaded with the drug piceatannol, a spleen tyrosine kinase (Syk) inhibitor, mitigated the effects of polymicrobial sepsis by reducing tissue inflammation while fully preserving neutrophilic host-defense function.
Collapse
Affiliation(s)
- Kurt Bachmaier
- Department
of Pharmacology and Regenerative Medicine and the Center for Lung
and Vascular Biology, The University of
Illinois College of Medicine, E403, 835 South Wolcott Avenue, Chicago, Illinois 60612, United States
- Nano
Biotherapeutics, Inc., 2201 West Campbell Park Drive, Chicago, Illinois 60612, United States
| | - Andrew Stuart
- Nano
Biotherapeutics, Inc., 2201 West Campbell Park Drive, Chicago, Illinois 60612, United States
| | - Abhalaxmi Singh
- Department
of Pharmacology and Regenerative Medicine and the Center for Lung
and Vascular Biology, The University of
Illinois College of Medicine, E403, 835 South Wolcott Avenue, Chicago, Illinois 60612, United States
- Nano
Biotherapeutics, Inc., 2201 West Campbell Park Drive, Chicago, Illinois 60612, United States
| | - Amitabha Mukhopadhyay
- Department
of Pharmacology and Regenerative Medicine and the Center for Lung
and Vascular Biology, The University of
Illinois College of Medicine, E403, 835 South Wolcott Avenue, Chicago, Illinois 60612, United States
| | - Sreeparna Chakraborty
- Department
of Pharmacology and Regenerative Medicine and the Center for Lung
and Vascular Biology, The University of
Illinois College of Medicine, E403, 835 South Wolcott Avenue, Chicago, Illinois 60612, United States
| | - Zhigang Hong
- Department
of Pharmacology and Regenerative Medicine and the Center for Lung
and Vascular Biology, The University of
Illinois College of Medicine, E403, 835 South Wolcott Avenue, Chicago, Illinois 60612, United States
| | - Li Wang
- Department
of Pharmacology and Regenerative Medicine and the Center for Lung
and Vascular Biology, The University of
Illinois College of Medicine, E403, 835 South Wolcott Avenue, Chicago, Illinois 60612, United States
- Division
of Cardiology, Department of Medicine, The
University of Illinois College of Medicine, Chicago, Illinois 60612, United States
| | - Yoshikazu Tsukasaki
- Department
of Pharmacology and Regenerative Medicine and the Center for Lung
and Vascular Biology, The University of
Illinois College of Medicine, E403, 835 South Wolcott Avenue, Chicago, Illinois 60612, United States
| | - Mark Maienschein-Cline
- Research
Resources Center, University of Illinois
at Chicago, Chicago, Illinois 60612, United States
| | - Balaji B. Ganesh
- Research
Resources Center, University of Illinois
at Chicago, Chicago, Illinois 60612, United States
| | - Prasad Kanteti
- Nano
Biotherapeutics, Inc., 2201 West Campbell Park Drive, Chicago, Illinois 60612, United States
| | - Jalees Rehman
- Department
of Pharmacology and Regenerative Medicine and the Center for Lung
and Vascular Biology, The University of
Illinois College of Medicine, E403, 835 South Wolcott Avenue, Chicago, Illinois 60612, United States
- Division
of Cardiology, Department of Medicine, The
University of Illinois College of Medicine, Chicago, Illinois 60612, United States
| | - Asrar B. Malik
- Department
of Pharmacology and Regenerative Medicine and the Center for Lung
and Vascular Biology, The University of
Illinois College of Medicine, E403, 835 South Wolcott Avenue, Chicago, Illinois 60612, United States
- Nano
Biotherapeutics, Inc., 2201 West Campbell Park Drive, Chicago, Illinois 60612, United States
| |
Collapse
|
4
|
Zhu D, Chen F, Chen YC, Peng H, Wang KJ. The Long-Term Effect of a Nine Amino-Acid Antimicrobial Peptide AS-hepc3 (48-56) Against Pseudomonas aeruginosa With No Detectable Resistance. Front Cell Infect Microbiol 2021; 11:752637. [PMID: 34676176 PMCID: PMC8523948 DOI: 10.3389/fcimb.2021.752637] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2021] [Accepted: 09/16/2021] [Indexed: 12/18/2022] Open
Abstract
The emergence of multidrug-resistant (MDR) pathogens has become a global public health crisis. Among them, MDR Pseudomonas aeruginosa is the main cause of nosocomial infections and deaths. Antimicrobial peptides (AMPs) are considered as competitive drug candidates to address this threat. In the study, we characterized two AMPs (AS-hepc3(41-71) and AS-hepc3(48-56)) that had potent activity against 5 new clinical isolates of MDR P. aeruginosa. Both AMPs destroyed the integrity of the cell membrane, induced leakage of intracellular components, and ultimately led to cell death. A long-term comparative study on the bacterial resistance treated with AS-hepc3(41-71), AS-hepc3(48-56) and 12 commonly used antibiotics showed that P. aeruginosa quickly developed resistance to the nine antibiotics tested (including aztreonam, ceftazidime, cefepime, imipenem, meropenem, ciprofloxacin, levofloxacin, gentamicin, and piperacillin) as early as 12 days after 150 days of successive culture generations. The initial effective concentration of 9 antibiotics against P. aeruginosa was greatly increased to a different high level at 150 days, however, both AS-hepc3(41-71) and AS-hepc3(48-56) maintained their initial MIC unchangeable through 150 days, indicating that P. aeruginosa did not produce any significant resistance to both AMPs. Furthermore, AS-hepc3(48-56) did not show any toxic effect on mammalian cells in vitro and mice in vivo. AS-hepc3(48-56) had a therapeutic effect on MDR P. aeruginosa infection using a mouse lung infection model and could effectively increase the survival rate of mice by inhibiting bacterial proliferation and attenuating lung inflammation. Taken together, the short peptide AS-hepc3(48-56) would be a promising agent for clinical treatment of MDR P. aeruginosa infections.
Collapse
Affiliation(s)
- Depeng Zhu
- State Key Laboratory of Marine Environmental Science, College of Ocean and Earth Sciences, Xiamen University, Xiamen, China
| | - Fangyi Chen
- State Key Laboratory of Marine Environmental Science, College of Ocean and Earth Sciences, Xiamen University, Xiamen, China.,State-Province Joint Engineering Laboratory of Marine Bioproducts and Technology, College of Ocean and Earth Sciences, Xiamen University, Xiamen, China.,Fujian Innovation Research Institute for Marine Biological Antimicrobial Peptide Industrial Technology, College of Ocean and Earth Sciences, Xiamen University, Xiamen, China
| | - Yan-Chao Chen
- State Key Laboratory of Marine Environmental Science, College of Ocean and Earth Sciences, Xiamen University, Xiamen, China
| | - Hui Peng
- State Key Laboratory of Marine Environmental Science, College of Ocean and Earth Sciences, Xiamen University, Xiamen, China.,State-Province Joint Engineering Laboratory of Marine Bioproducts and Technology, College of Ocean and Earth Sciences, Xiamen University, Xiamen, China.,Fujian Innovation Research Institute for Marine Biological Antimicrobial Peptide Industrial Technology, College of Ocean and Earth Sciences, Xiamen University, Xiamen, China
| | - Ke-Jian Wang
- State Key Laboratory of Marine Environmental Science, College of Ocean and Earth Sciences, Xiamen University, Xiamen, China.,State-Province Joint Engineering Laboratory of Marine Bioproducts and Technology, College of Ocean and Earth Sciences, Xiamen University, Xiamen, China.,Fujian Innovation Research Institute for Marine Biological Antimicrobial Peptide Industrial Technology, College of Ocean and Earth Sciences, Xiamen University, Xiamen, China
| |
Collapse
|
5
|
Mandal P, Lyons JD, Burd EM, Koval M, Mocarski ES, Coopersmith CM. Integrated evaluation of lung disease in single animals. PLoS One 2021; 16:e0246270. [PMID: 34237078 PMCID: PMC8266100 DOI: 10.1371/journal.pone.0246270] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2020] [Accepted: 01/15/2021] [Indexed: 11/18/2022] Open
Abstract
During infectious disease, pathogen load drives inflammation and immune response that together contribute to tissue injury often resulting in organ dysfunction. Pulmonary failure in SARS-CoV2-infected hospitalized COVID-19 patients is one such prominent example. Intervention strategies require characterization of the host-pathogen interaction by accurately assessing all of the above-mentioned disease parameters. To study infection in intact mammals, mice are often used as essential genetic models. Due to humane concerns, there is a constant unmet demand to develop studies that reduce the number of mice utilized while generating objective data. Here, we describe an integrated method of evaluating lung inflammation in mice infected with Pseudomonas aeruginosa or murine gammaherpesvirus (MHV)-68. This method conserves animal resources while permitting evaluation of disease mechanisms in both infection settings. Lungs from a single euthanized mouse were used for two purposes-biological assays to determine inflammation and infection load, as well as histology to evaluate tissue architecture. For this concurrent assessment of multiple parameters from a single euthanized mouse, we limit in-situ formalin fixation to the right lung of the cadaver. The unfixed left lung is collected immediately and divided into several segments for biological assays including determination of pathogen titer, assessment of infection-driven cytokine levels and appearance of cell death markers. In situ fixed right lung was then processed for histological determination of tissue injury and confirmation of infection-driven cell death patterns. This method reduces overall animal use and minimizes inter-animal variability that results from sacrificing different animals for different types of assays. The technique can be applied to any lung disease study in mice or other mammals.
Collapse
Affiliation(s)
- Pratyusha Mandal
- Department of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, United States of America
| | - John D. Lyons
- Department of Surgery, Emory Critical Care Center, Emory University School of Medicine, Atlanta, GA, United States of America
| | - Eileen M. Burd
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States of America
| | - Michael Koval
- Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine and Department of Cell Biology, Emory University School of Medicine, Atlanta, GA, United States of America
| | - Edward S. Mocarski
- Department of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, United States of America
| | - Craig M. Coopersmith
- Department of Surgery, Emory Critical Care Center, Emory University School of Medicine, Atlanta, GA, United States of America
| |
Collapse
|
6
|
Finn J, Sottoriva K, Pajcini KV, Kitajewski JK, Chen C, Zhang W, Malik AB, Liu Y. Dlk1-Mediated Temporal Regulation of Notch Signaling Is Required for Differentiation of Alveolar Type II to Type I Cells during Repair. Cell Rep 2020; 26:2942-2954.e5. [PMID: 30865885 PMCID: PMC6464111 DOI: 10.1016/j.celrep.2019.02.046] [Citation(s) in RCA: 68] [Impact Index Per Article: 17.0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2018] [Revised: 01/15/2019] [Accepted: 02/12/2019] [Indexed: 01/26/2023] Open
Abstract
Lung alveolar type I cells (AT1) and alveolar type II cells (AT2) regulate the structural integrity and function of alveoli. AT1, covering ∼95% of the surface area, are responsible for gas exchange, whereas AT2 serve multiple functions, including alveolar repair through proliferation and differentiation into AT1. However, the signaling mechanisms for alveolar repair remain unclear. Here, we demonstrate, in Pseudomonas aeruginosa-induced acute lung injury in mice, that non-canonical Notch ligand Dlk1 (delta-like 1 homolog) is essential for AT2-to-AT1 differentiation. Notch signaling was activated in AT2 at the onset of repair but later suppressed by Dlk1. Deletion of Dlk1 in AT2 induced persistent Notch activation, resulting in stalled transition to AT1 and accumulation of an intermediate cell population that expressed low levels of both AT1 and AT2 markers. Thus, Dlk1 expression leads to precisely timed inhibition of Notch signaling and activates AT2-to-AT1 differentiation, leading to alveolar repair.
Collapse
Affiliation(s)
- Johanna Finn
- Department of Pharmacology, The University of Illinois College of Medicine, Chicago, IL 60612, USA; The Center for Lung and Vascular Biology, The University of Illinois College of Medicine, Chicago, IL 60612, USA
| | - Kilian Sottoriva
- Department of Pharmacology, The University of Illinois College of Medicine, Chicago, IL 60612, USA
| | - Kostandin V Pajcini
- Department of Pharmacology, The University of Illinois College of Medicine, Chicago, IL 60612, USA
| | - Jan K Kitajewski
- Department of Physiology and Biophysics, The University of Illinois College of Medicine, Chicago, IL 60612, USA
| | - Chang Chen
- Department of Bioengineering, University of Illinois at Chicago, Chicago, IL 60607, USA; Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
| | - Wei Zhang
- Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
| | - Asrar B Malik
- Department of Pharmacology, The University of Illinois College of Medicine, Chicago, IL 60612, USA; The Center for Lung and Vascular Biology, The University of Illinois College of Medicine, Chicago, IL 60612, USA
| | - Yuru Liu
- Department of Pharmacology, The University of Illinois College of Medicine, Chicago, IL 60612, USA; The Center for Lung and Vascular Biology, The University of Illinois College of Medicine, Chicago, IL 60612, USA.
| |
Collapse
|
7
|
Chambers ED, White A, Vang A, Wang Z, Ayala A, Weng T, Blackburn M, Choudhary G, Rounds S, Lu Q. Blockade of equilibrative nucleoside transporter 1/2 protects against Pseudomonas aeruginosa-induced acute lung injury and NLRP3 inflammasome activation. FASEB J 2020; 34:1516-1531. [PMID: 31914698 PMCID: PMC7045807 DOI: 10.1096/fj.201902286r] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2019] [Revised: 11/13/2019] [Accepted: 11/14/2019] [Indexed: 11/11/2022]
Abstract
Pseudomonas aeruginosa infections are increasingly multidrug resistant and cause healthcare-associated pneumonia, a major risk factor for acute lung injury (ALI)/acute respiratory distress syndrome (ARDS). Adenosine is a signaling nucleoside with potential opposing effects; adenosine can either protect against acute lung injury via adenosine receptors or cause lung injury via adenosine receptors or equilibrative nucleoside transporter (ENT)-dependent intracellular adenosine uptake. We hypothesized that blockade of intracellular adenosine uptake by inhibition of ENT1/2 would increase adenosine receptor signaling and protect against P. aeruginosa-induced acute lung injury. We observed that P. aeruginosa (strain: PA103) infection induced acute lung injury in C57BL/6 mice in a dose- and time-dependent manner. Using ENT1/2 pharmacological inhibitor, nitrobenzylthioinosine (NBTI), and ENT1-null mice, we demonstrated that ENT blockade elevated lung adenosine levels and significantly attenuated P. aeruginosa-induced acute lung injury, as assessed by lung wet-to-dry weight ratio, BAL protein levels, BAL inflammatory cell counts, pro-inflammatory cytokines, and pulmonary function (total lung volume, static lung compliance, tissue damping, and tissue elastance). Using both agonists and antagonists directed against adenosine receptors A2AR and A2BR, we further demonstrated that ENT1/2 blockade protected against P. aeruginosa -induced acute lung injury via activation of A2AR and A2BR. Additionally, ENT1/2 chemical inhibition and ENT1 knockout prevented P. aeruginosa-induced lung NLRP3 inflammasome activation. Finally, inhibition of inflammasome prevented P. aeruginosa-induced acute lung injury. Our results suggest that targeting ENT1/2 and NLRP3 inflammasome may be novel strategies for prevention and treatment of P. aeruginosa-induced pneumonia and subsequent ARDS.
Collapse
Affiliation(s)
- Eboni D. Chambers
- Vascular Research Laboratory, Providence Veterans Affairs Medical Center, Alpert Medical School of Brown University, Providence, RI 02908
| | - Alexis White
- Vascular Research Laboratory, Providence Veterans Affairs Medical Center, Alpert Medical School of Brown University, Providence, RI 02908
| | - Alexander Vang
- Vascular Research Laboratory, Providence Veterans Affairs Medical Center, Alpert Medical School of Brown University, Providence, RI 02908
| | - Zhengke Wang
- Vascular Research Laboratory, Providence Veterans Affairs Medical Center, Alpert Medical School of Brown University, Providence, RI 02908
| | - Alfred Ayala
- Division of Surgical Research, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI 02908
| | - Tingting Weng
- Departments of Biochemistry and Molecular Biology, University of Texas-Houston Medical School, Houston, TX 77030
| | - Michael Blackburn
- Departments of Biochemistry and Molecular Biology, University of Texas-Houston Medical School, Houston, TX 77030
| | - Gaurav Choudhary
- Vascular Research Laboratory, Providence Veterans Affairs Medical Center, Alpert Medical School of Brown University, Providence, RI 02908
| | - Sharon Rounds
- Vascular Research Laboratory, Providence Veterans Affairs Medical Center, Alpert Medical School of Brown University, Providence, RI 02908
| | - Qing Lu
- Vascular Research Laboratory, Providence Veterans Affairs Medical Center, Alpert Medical School of Brown University, Providence, RI 02908
| |
Collapse
|
8
|
Fan Y, Zhang G, Vong CT, Ye RD. Serum amyloid A3 confers protection against acute lung injury in Pseudomonas aeruginosa-infected mice. Am J Physiol Lung Cell Mol Physiol 2019; 318:L314-L322. [PMID: 31851532 DOI: 10.1152/ajplung.00309.2019] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
Pseudomonas aeruginosa is a gram-negative bacterium associated with serious illnesses, including ventilator-associated pneumonia and various sepsis syndromes in humans. Understanding the host immune mechanisms against P. aeruginosa is, therefore, of clinical importance. The present study identified serum amyloid A3 (SAA3) as being highly inducible in mouse bronchial epithelium following P. aeruginosa infection. Genetic deletion of Saa3 rendered mice more susceptible to P. aeruginosa infection with decreased neutrophil superoxide anion production, and ex vivo treatment of mouse neutrophils with recombinant SAA3 restored the ability of neutrophils to produce superoxide anions. The SAA3-deficient mice showed exacerbated inflammatory responses, which was characterized by pronounced neutrophil infiltration, elevated expression of TNF-α, KC/CXCL1, and MIP-2/CXCL2 in bronchoalveolar lavage fluid (BALF), and increased lung microvascular permeability compared with their wild-type littermates. BALF neutrophils from Saa3 knockout mice exhibited reduced superoxide anion production compared with neutrophils from wild-type mice. Adoptive transfer of SAA3-treated neutrophils to Saa3 knockout mice ameliorated P. aeruginosa-induced acute lung injury. These findings demonstrate that SAA3 not only serves as a biomarker for infection and inflammation, but also plays a protective role against P. aeruginosa infection-induced lung injury in part through augmentation of neutrophil bactericidal functions.
Collapse
Affiliation(s)
- Yu Fan
- State Key Laboratory for Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau Special Administrative Region, China
| | - Gufang Zhang
- School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China
| | - Chi Teng Vong
- State Key Laboratory for Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau Special Administrative Region, China
| | - Richard D Ye
- State Key Laboratory for Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau Special Administrative Region, China.,School of Life and Health Sciences, The Chinese University of Hong Kong, Shenzhen, China
| |
Collapse
|
9
|
Ebenezer DL, Fu P, Krishnan Y, Maienschein-Cline M, Hu H, Jung S, Madduri R, Arbieva Z, Harijith A, Natarajan V. Genetic deletion of Sphk2 confers protection against Pseudomonas aeruginosa mediated differential expression of genes related to virulent infection and inflammation in mouse lung. BMC Genomics 2019; 20:984. [PMID: 31842752 PMCID: PMC6916461 DOI: 10.1186/s12864-019-6367-9] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2019] [Accepted: 12/03/2019] [Indexed: 02/07/2023] Open
Abstract
BACKGROUND Pseudomonas aeruginosa (PA) is an opportunistic Gram-negative bacterium that causes serious life threatening and nosocomial infections including pneumonia. PA has the ability to alter host genome to facilitate its invasion, thus increasing the virulence of the organism. Sphingosine-1- phosphate (S1P), a bioactive lipid, is known to play a key role in facilitating infection. Sphingosine kinases (SPHK) 1&2 phosphorylate sphingosine to generate S1P in mammalian cells. We reported earlier that Sphk2-/- mice offered significant protection against lung inflammation, compared to wild type (WT) animals. Therefore, we profiled the differential expression of genes between the protected group of Sphk2-/- and the wild type controls to better understand the underlying protective mechanisms related to the Sphk2 deletion in lung inflammatory injury. Whole transcriptome shotgun sequencing (RNA-Seq) was performed on mouse lung tissue using NextSeq 500 sequencing system. RESULTS Two-way analysis of variance (ANOVA) analysis was performed and differentially expressed genes following PA infection were identified using whole transcriptome of Sphk2-/- mice and their WT counterparts. Pathway (PW) enrichment analyses of the RNA seq data identified several signaling pathways that are likely to play a crucial role in pneumonia caused by PA such as those involved in: 1. Immune response to PA infection and NF-κB signal transduction; 2. PKC signal transduction; 3. Impact on epigenetic regulation; 4. Epithelial sodium channel pathway; 5. Mucin expression; and 6. Bacterial infection related pathways. Our genomic data suggests a potential role for SPHK2 in PA-induced pneumonia through elevated expression of inflammatory genes in lung tissue. Further, validation by RT-PCR on 10 differentially expressed genes showed 100% concordance in terms of vectoral changes as well as significant fold change. CONCLUSION Using Sphk2-/- mice and differential gene expression analysis, we have shown here that S1P/SPHK2 signaling could play a key role in promoting PA pneumonia. The identified genes promote inflammation and suppress others that naturally inhibit inflammation and host defense. Thus, targeting SPHK2/S1P signaling in PA-induced lung inflammation could serve as a potential therapy to combat PA-induced pneumonia.
Collapse
Affiliation(s)
- David L Ebenezer
- Department of Pharmacology, University of Illinois, Chicago, USA
| | - Panfeng Fu
- Department of Pharmacology, University of Illinois, Chicago, USA
| | | | | | - Hong Hu
- Department of Bioinformatics, University of Illinois, Chicago, USA
| | - Segun Jung
- Globus, University of Chicago, Chicago, IL, USA
| | - Ravi Madduri
- Globus, University of Chicago, Chicago, IL, USA
- Argonne National Laboratory, Chicago, IL, USA
| | - Zarema Arbieva
- Department of Core Genomics Facility, University of Illinois, Chicago, USA
| | - Anantha Harijith
- Department of Pediatrics, University of Illinois, Room 3139, COMRB Building, 909, South Wolcott Avenue, Chicago, IL, 60612, USA.
| | - Viswanathan Natarajan
- Department of Pharmacology, University of Illinois, Chicago, USA
- Department of Medicine, University of Illinois, Chicago, USA
| |
Collapse
|